Harjeet Singh

Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells

S. Olivares, Harjeet Singh, H. Huls, 2013, PloS one.

Abstract 4745: Quantitative single-cell functional characterization of CD19-specific CAR+ T Cells for immunotherapy.

Ivan Liadi, Gabrielle Romain, Navin Varadarajan, 2013 .

Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

Peng Qiu, Badrinath Roysam, Amine Merouane, 2015, Cancer Immunology Research.

A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19

Harjeet Singh, H. Huls, L. Cooper, 2014, Immunological reviews.

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Katy Rezvani, David A Largaespada, Jianliang Dai, 2016, The Journal of clinical investigation.